159 related articles for article (PubMed ID: 28900718)
1. Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion.
Porcel JM; Solé C; Salud A; Bielsa S
Lung; 2017 Dec; 195(6):775-779. PubMed ID: 28900718
[TBL] [Abstract][Full Text] [Related]
2. Important prognostic factors for survival in patients with malignant pleural effusion.
Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
[TBL] [Abstract][Full Text] [Related]
3. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
[TBL] [Abstract][Full Text] [Related]
4. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
[TBL] [Abstract][Full Text] [Related]
5. Palliative treatment of malignant pleural effusions by video-assisted thoracoscopic surgery.
Benkó I; Molnár TF; Horváth OP
Acta Chir Hung; 1999; 38(2):131-3. PubMed ID: 10596313
[TBL] [Abstract][Full Text] [Related]
6. [Survival of malignant and paramalignant pleural effusions in Ouagadougou].
Bambara AT; Ouédraogo SM; Maïga S; Sondo KA; Boncoungou/Nikièma K; Ouédraogo G; Koumbem B; Ouédraogo AS; Djibril M; Badoum G; Ouédraogo AR; Ouédraogo M
Rev Pneumol Clin; 2016 Dec; 72(6):346-352. PubMed ID: 27776946
[TBL] [Abstract][Full Text] [Related]
7. Closing faucets: the role of anti-angiogenic therapies in malignant pleural diseases.
Marquez-Medina D; Popat S
Clin Transl Oncol; 2016 Aug; 18(8):760-8. PubMed ID: 26680633
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
[TBL] [Abstract][Full Text] [Related]
9. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions.
Kasapoglu US; Arınç S; Gungor S; Irmak I; Guney P; Aksoy F; Bandak D; Hazar A
Clin Respir J; 2016 Nov; 10(6):791-799. PubMed ID: 25764010
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value and Therapeutic Implications of Pleural Carcinosis and Malignant Pleural Effusion in Advanced Epithelial Ovarian Cancer.
Nasser S; Fotopoulou C; Richter R; Kaulich J; Braicu E; Beteta C; Olschewski J; Babayeva A; Sehouli J
Anticancer Res; 2021 Apr; 41(4):2033-2038. PubMed ID: 33813410
[TBL] [Abstract][Full Text] [Related]
12. Malignant Pleural Effusion at Presentation in Patients with Small-Cell Lung Cancer.
Shojaee S; Singh I; Solsky I; Nana-Sinkam P
Respiration; 2019; 98(3):198-202. PubMed ID: 31121583
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic significance of receptor-binding cancer antigen expressed on SiSo cells in lung-cancer-associated pleural effusion.
Yang J; Zhu Y; Wu L; Zhu W; Zhang X; Yang Y; Xu C
Clin Respir J; 2018 Jan; 12(1):279-284. PubMed ID: 27402224
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
[TBL] [Abstract][Full Text] [Related]
15. The current aetiology of malignant pleural effusion in the Western Cape Province, South Africa.
Koegelenberg CFN; Bennji SM; Boer E; Schubert PT; Shaw JA; Allwood BW; Irusen EM
S Afr Med J; 2018 Mar; 108(4):275-277. PubMed ID: 29629675
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis].
Chella A; Ribechini A; Dini P; Adamo C; Mussi A; Angeletti CA
Minerva Chir; 1994 Nov; 49(11):1077-82. PubMed ID: 7708227
[TBL] [Abstract][Full Text] [Related]
17. Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis.
Lombardi G; Nicoletto MO; Gusella M; Fiduccia P; Dalla Palma M; Zuin A; Fiore D; Donach M; Zagonel V
Cancer Chemother Pharmacol; 2012 Mar; 69(3):781-7. PubMed ID: 22037881
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of pleural fluid data in patients with malignant effusion.
Bielsa S; Salud A; Martínez M; Esquerda A; Martín A; Rodríguez-Panadero F; Porcel JM
Eur J Intern Med; 2008 Jul; 19(5):334-9. PubMed ID: 18549935
[TBL] [Abstract][Full Text] [Related]
19. An Observational Study Evaluating the Performance of LENT Score in the Selected Population of Malignant Pleural Effusion from Lung Adenocarcinoma in Singapore.
Abisheganaden J; Verma A; Dagaonkar RS; Light RW
Respiration; 2018; 96(4):308-313. PubMed ID: 29945142
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Measurement of Pleural Fluid Biochemistry and Cytokines in Malignant Pleural Effusions.
Thomas R; Cheah HM; Creaney J; Turlach BA; Lee YC
Chest; 2016 Jun; 149(6):1494-500. PubMed ID: 26836920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
